Alvimopan
SIGMA/SML1347 - ≥98% (HPLC)
Synonym: ADL-8-2698; LY-246736; N-
CAS Number: 156053-89-3
Empirical Formula (Hill Notation): C25H32N2O4
Molecular Weight: 424.53
MDL Number: MFCD09838268
Linear Formula: C25H32N2O4
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C25H32N2O4/c1-18-16-27 |
| InChI key | UPNUIXSCZBYVBB-JVFUWBCBSA |
| optical activity | [α]/D +46 to +52°, c = 1.0 in DMSO |
| Quality Level | 100 ![]() |
| SMILES string | C[C@H]1CN(C[C@@H](C(NCC(O |
| solubility | DMSO: 10 mg/mL, clear |
| storage temp. | 2-8°C |
| Biochem/physiol Actions: | Alvimopan is a gastroprokinetic peripheral mu-opioid receptor antagonist. |
| Biochem/physiol Actions: | Alvimopan is a gastroprokinetic peripheral mu-opioid receptor antagonist. As a drug, Alvimopan is given to patients undergoing bowel surgery to protect the bowel from the effects of opioid medications that are used to treat pain, blocking the undesirable GI side-effects of the opioid agonists without affecting analgesia or causing withdrawal. Alvimopan does not cross the blood-brain barrier, competitively binding to gastrointestinal tract mu-opioid receptors. |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol | ![]() GHS07,GHS09 |
| Signal word | Warning |
| Hazard statements | H315 - H319 - H400 |
| Precautionary statements | P273 - P302 + P352 - P305 + P351 + P338 |
| RIDADR | UN 3077 9 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |



